Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jesús Estellés"'
Autor:
Lidia Marti Romero, Jesús Estellés Arnau, Jose Manuel Querol Ribelles, Inmaculada Castelló Miralles, Vanesa Martínez Escapa
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 111(6)
The current treatment of choice for inoperable and/or unresectable biliopancreatic neoplasms complicated by jaundice is the placement of metal biliary stents. The most common complication is obstruction due to tumor growth. The application of radiofr
Autor:
J.L. Mendoza, Guillermo Bastida, Cristina Saro, S. Garcia-Morán, Jesús Estellés, Elena Gento, Isabel Vera, Ignacio Fernández-Blanco, M. Barreiro-de Acosta, María Chaparro Sánchez, Pilar Martínez-Montiel, Olga Merino, Ignacio Marín-Jiménez, Valle García-Sánchez, Javier P. Gisbert, Carlos Taxonera
Publikováno v:
Alimentary Pharmacology & Therapeutics. 33:340-348
Aliment Pharmacol Ther 2011; 33: 340–348 Summary Background The long-term efficacy of adalimumab in patients with ulcerative colitis is not well known. Aim To evaluate the short- and long-term outcomes of adalimumab in ulcerative colitis patients p
Autor:
Pilar López-Serrano, Antonio Roman, Alfonso Muriel, Jesús Estellés, Ángel Ponferrada, Pablo M. Linares, Carlos Teruel, José Lázaro Pérez-Calle, Javier P. Gisbert, Alicia Algaba, Carlos Taxonera, Manuel Van Domselaar, Fernando Bermejo, María Dolores Martín-Arranz
Publikováno v:
American Journal of Gastroenterology. 105:2003-2008
Immunomodulators are used as maintenance treatment of inflammatory bowel disease (IBD). Data regarding their possible effects in the course of pregnancy when the father is exposed at the time of conception are limited.To evaluate the outcomes of preg
Autor:
R. Pajares, Yago González-Lama, Fernando Bermejo, V. Opio, Javier P. Gisbert, Alicia Algaba, Antonio López-Sanromán, Jesús Estellés, Almudena Barbero, Jose Luis Mate, José Lázaro Pérez-Calle, J.L. Mendoza, Juan L. Mendoza, P. López, Carlos Taxonera, Adrian G. McNicholl
Publikováno v:
European journal of gastroenterologyhepatology. 24(9)
Background Methotrexate is useful in inflammatory bowel disease (IBD), but its role is secondary because of its limited experience and a supposedly unfavorable safety profile. Aim To describe the efficacy and safety of methotrexate in a long-term rea
Autor:
Ignacio Blanco, Carlos Taxonera, Pilar Martínez, Cristina Saro, Isabel Vera, Jesús Estellés, Ignacio Marín-Jiménez, Guillermo Bastida, Javier P. Gisbert, Valle Garcia, Juan L. Mendoza, Elena Gento, Manuel Barreiro, Olga Merino
Publikováno v:
Gastroenterology. 138:S-61
Autor:
Carlos Taxonera, Alicia Algaba, Antonio Roman, José Lázaro Pérez-Calle, Javier P. Gisbert, Pilar López-Serrano, Pablo M. Linares, María Dolores Martín-Arranz, Jesús Estellés, Fernando Bermejo, Carlos Teruel, Manuel Van Domselaar
Publikováno v:
Gastroenterology. 136:A-87
Autor:
A. Barbero, V. Opio, Yago González-Lama, Adrian G. McNicholl, P. López, Antonio López-Sanromán, Alicia Algaba, Carlos Taxonera, R. Pajares, Juan Luis Mendoza, Francisco Javier Bermejo, J. Maté, Juan L. Mendoza, J.L. Pérez-Calle, J.P. Gisbert, Jesús Estellés
Publikováno v:
Gastroenterología y Hepatología. 32:214
Introduccion Existe evidencia de la utilidad del metotrexato (MTX) en la enfermedad inflamatoria intestinal (EII), pero su papel en la actualidad es secundario, principalmente por una falta de experiencia en su uso y un supuesto perfil desfavorable d